Spatial context of adipose tissue macrophages in obesity
肥胖症中脂肪组织巨噬细胞的空间背景
基本信息
- 批准号:10287708
- 负责人:
- 金额:$ 11.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipocytesAdipose tissueAnatomyApoptoticArchitectureBiogenesisBiological AssayCardiovascular DiseasesCellsCessation of lifeChronicDataDental crownsDevelopmentDiabetes MellitusDiseaseFoundationsFunctional disorderGene ExpressionGene Expression ProfileGoalsHealthHumanITGAX geneImageImmuneImmune systemInflammationInsulin ResistanceInvestigationKnowledgeLinkLipidsLocationLysosomesMacrophage ActivationMapsMediator of activation proteinMetabolicMetabolic DiseasesMetabolic dysfunctionMetabolismMethodsModelingMolecular ProfilingMorbidity - disease rateMusMyeloid CellsObesityObesity associated diseaseOverweightPhysiologicalProductionPublishingResearchResolutionRiskRoleSignal TransductionSolidStainsStressStructureTechniquesTimeTissue ExpansionTissuesUnited StatesWorkcohortcostcytokinegenome-widein vivomacrophagemouse modelnew therapeutic targetnovel strategiespreservationprogramsscavenger receptorspatial relationshiptranscriptome sequencingtranscriptomics
项目摘要
PROJECT SUMMARY
Adipose tissue inflammation is a known link between obesity and metabolic dysfunction and is associated with
accumulation of adipose tissue macrophages (ATM). However, the interplay between ATMs and obese tissue
inflammation and tissue expansion is still not well understood. Unbiased techniques such as RNA-sequencing
of whole tissue or single cells have been extremely useful in characterizing adipose tissue cellular changes with
obesity, though these methods lose anatomical context. The fine detail of tissue architecture and ATMs within
their anatomical niche is a critical aspect of understanding their function in vivo, but methods such as
immunolabeling can only detect a small subset of known markers and structures. Here I propose to use the
recently available method of spatial transcriptomics (STX) to capture gene expression signatures across adipose
tissue, retaining anatomical context of cell signatures and near single cell resolution. My preliminary data validate
the feasibility of this approach for adipose tissue and identify lysosomal signatures in scavenger receptor high
(SRhi) ATMs as a high priority target for investigation in obesity and diabetes. In conjunction with STX, I will
perform single cell transcriptomics to delineate representative ATM and adipocyte signatures, which I will use to
generate spatial maps of ATM-adipocyte niches during obesity. My overall goal is to map SRhi and SRlo ATM
niches within adipose tissue in metabolic dysfunction. My central hypothesis is that dysfunctional lysosomal
processing during SRlo ATM clearance of dying adipocytes precedes internal lipid accumulation and aggregation
into proinflammatory crown-like structures (CLS). To examine this hypothesis, I will investigate ATMs and
adipocytes in STX and single cell transcriptomics data and ATM lysosomal function in a time course of murine
obesity. My research aims are: (1) Identify ATM niches and their lysosomal signatures in obese adipose tissue.
I will examine the hypothesis that the anatomical niche of SRlo ATMs promotes lysosomal stress during interface
with apoptotic adipocytes prior to CLS formation. Single cell transcriptomics will enable identification of prominent
ATM subsets across the time course, and I will map these signatures to specific anatomical locations within
adipose tissue. (2) Determine lysosomal function, lipid accumulation, and proinflammatory cytokine production
in SRhi and SRlo ATMs. I will examine the hypothesis with increased duration of obesity, lysosomal stress in SRlo
ATMs associates with lipid accumulation and production of proinflammatory mediators prior to development of
insulin resistance. To determine lysosomal signatures and function, lipid-laden vs. lipid-lo ATMs from the time
course will be examined through bulk RNA-sequencing, lysosomal staining and quantification, and assays to
identify mediators of lysosomal stress and lipid accumulation. The proposed work develops a new line of my
research focusing on a murine model of obesity, paralleling my human K01 work. Together, these projects will
provide a solid foundation for my independent research program and preliminary data toward an R01 application
within two years.
项目摘要
脂肪组织炎症是肥胖和代谢功能障碍之间的已知联系,与
脂肪组织巨噬细胞的积累(ATM)。但是,ATM和肥胖组织之间的相互作用
炎症和组织扩张仍然不太了解。公正的技术,例如RNA序列
整个组织或单个细胞的表征脂肪组织细胞变化非常有用
肥胖,尽管这些方法失去了解剖环境。组织结构和自动取款机的细节
他们的解剖学利基是理解其在体内功能的关键方面,但是诸如
免疫标记只能检测到一小部分已知标记和结构。在这里我建议使用
最近可用的空间转录组学方法(STX)捕获脂肪跨越基因表达的特征
组织,保留细胞特征的解剖环境和接近单细胞的分辨率。我的初步数据验证
这种方法对于脂肪组织的可行性并鉴定清道夫受体中的溶酶体特征
(SRHI)ATM作为肥胖和糖尿病研究的高优先级目标。与STX结合,我将
执行单细胞转录组学以描述代表性的ATM和脂肪细胞特征,我将使用它们
在肥胖期间生成ATM-脂肪细胞生态位的空间图。我的总体目标是映射SRHI和SRLO ATM
代谢功能障碍中脂肪组织内的壁ni。我的中心假设是功能失调的溶酶体
垂死脂肪细胞的SRLO ATM清除期间的加工前脂质内部脂质积累和聚集
进入促炎性冠状结构(CLS)。为了审查这一假设,我将研究ATM和
在鼠的时间过程中,STX和单细胞转录组数据和ATM溶酶体功能的脂肪细胞
肥胖。我的研究目的是:(1)确定肥胖脂肪组织中的ATM生态位及其溶酶体特征。
我将研究以下假设:SRLO ATMS的解剖壁基促进界面期间的溶酶体应力
在CLS形成之前与凋亡脂肪细胞。单细胞转录组学将使显着识别
在整个时间课程中的ATM子集,我将这些签名映射到特定的解剖位置
脂肪组织。 (2)确定溶酶体功能,脂质积累和促炎细胞因子的产生
在SRHI和SRLO ATMS中。我将随着肥胖持续时间,SRLO中的溶酶体应激的持续时间增加的假设
在开发之前
胰岛素抵抗。为了确定溶酶体特征和功能,从脂质含量和脂质-LO ATM开始
课程将通过大量RNA测序,溶酶体染色和定量进行检查,并进行测定
鉴定溶酶体应激和脂质积累的介体。拟议的工作开发了我的新系列
研究重点是肥胖模型,与我的人类K01工作相似。这些项目将在一起
为我的独立研究计划提供坚实的基础,并向R01应用程序提供初步数据
在两年内。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lindsey Allison Muir其他文献
Lindsey Allison Muir的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lindsey Allison Muir', 18)}}的其他基金
Spatial context of adipose tissue macrophages in obesity
肥胖症中脂肪组织巨噬细胞的空间背景
- 批准号:
10438853 - 财政年份:2021
- 资助金额:
$ 11.7万 - 项目类别:
Myeloid lineage activation and reprogramming in metabolic dysfunction
代谢功能障碍中的骨髓谱系激活和重编程
- 批准号:
10242720 - 财政年份:2018
- 资助金额:
$ 11.7万 - 项目类别:
相似国自然基金
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
- 批准号:82360615
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Arid5b调控Treg细胞脂肪组织适应性发育和代谢调控功能及机制探究
- 批准号:82371752
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
巨噬细胞Lp-PLA2对脂肪组织重塑的调控及其作用机制
- 批准号:32300977
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
巨噬细胞介导脂肪组织重构在塑化剂干扰系统能量代谢中的作用研究
- 批准号:82373625
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Multimodal omics approach to identify health to cardiometabolic disease transitions
多模式组学方法确定健康状况向心脏代谢疾病的转变
- 批准号:
10753664 - 财政年份:2023
- 资助金额:
$ 11.7万 - 项目类别:
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
- 批准号:
10619176 - 财政年份:2023
- 资助金额:
$ 11.7万 - 项目类别:
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
- 批准号:
10733720 - 财政年份:2023
- 资助金额:
$ 11.7万 - 项目类别:
Role of Pcpe2 in Adipose Tissue Remodeling and Lipoprotein Metabolism
Pcpe2 在脂肪组织重塑和脂蛋白代谢中的作用
- 批准号:
10837655 - 财政年份:2023
- 资助金额:
$ 11.7万 - 项目类别: